Ibupro­fen might treat Alzheimer’s: study

The Daily News Egypt - - Front Page -

A re­cent study pub­lished by the Univer­sity of Bri­tish Columbia re­vealed that tak­ing small doses of the painkiller Ibupro­fen can re­duce the risk of Alzheimer’s dis­ease.

The study shows that through a saliva test, the at-risk pa­tients can re­duce the risk of de­vel­op­ing Alzheimer’s through tak­ing small doses of the medicine, used for treat­ing pain, for the rest of their lives.

“In­di­vid­u­als can pre­vent that from hap­pen­ing through a sim­ple solution that re­quires no pre­scrip­tion or visit to a doc­tor,” the study’s lead au­thor Patrick McGeer wrote in the study, pub­lished in the jour­nal IOS Press. He added, “this is a true break­through since it points in a di­rec­tion where Alzheimer’s can even­tu­ally be elim­i­nated. If it is ap­plied world­wide, Alzheimer’s would dis­ap­pear.Our dis­cov­ery is a game changer.”

Ac­cord­ing to Alzheimer’s Dis­ease In­ter­na­tional’s World Alzheimer Re­port 2016, Alzheimer’s dis­ease af­fects an es­ti­mated 47 mil­lion peo­ple world­wide, costs health­care sys­tems world­wide more than $818bn per year and is the fifth lead­ing cause of death in those aged 65 or older.

“Know­ing that the preva­lence of clin­i­cal Alzheimer’s dis­ease com­mences at age 65, we rec­om­mend that peo­ple get tested 10 years be­fore, at age 55, when the on­set of Alzheimer’s would typ­i­cally be­gin,” McGeer said.

Tak­ing small doses of the medicine for the rest of in risk-pa­tients’ lives re­duces the risk of hav­ing Alzheimer’s

Newspapers in English

Newspapers from Egypt

© PressReader. All rights reserved.